Barclays maintains an 'Equalweight' on Corrections Corporation (CXW); Increasing Estimates for OH Win
Get Alerts CXW Hot Sheet
Price: $15.13 --0%
Rating Summary:
6 Buy, 2 Hold, 0 Sell
Rating Trend: Up
Today's Overall Ratings:
Up: 10 | Down: 8 | New: 7
Rating Summary:
6 Buy, 2 Hold, 0 Sell
Rating Trend: Up
Today's Overall Ratings:
Up: 10 | Down: 8 | New: 7
Join SI Premium – FREE
Barclays maintains an 'Equalweight' on Corrections Corporation of America (NYSE: CXW) price target of $25.00.
Barclays analyst says, "The Ohio Department of Rehabilitation and Correction (OH) announced yesterday (Sep 1 2011) its decision to sell the 1,798-bed Lake Erie Correctional Institution (Conneaut, OH; currently managed by MTC) to CXW for $73mn. Generally speaking, we view this as a positive and opportunistic deal by CXW. We raise our 2012E EPS estimate. (from $1.52 to $1.57)"
For more ratings news on Corrections Corporation of America click here and for the rating history of Corrections Corporation of America click here.
Shares of Corrections Corporation of America closed at $22.51 yesterday.
Barclays analyst says, "The Ohio Department of Rehabilitation and Correction (OH) announced yesterday (Sep 1 2011) its decision to sell the 1,798-bed Lake Erie Correctional Institution (Conneaut, OH; currently managed by MTC) to CXW for $73mn. Generally speaking, we view this as a positive and opportunistic deal by CXW. We raise our 2012E EPS estimate. (from $1.52 to $1.57)"
For more ratings news on Corrections Corporation of America click here and for the rating history of Corrections Corporation of America click here.
Shares of Corrections Corporation of America closed at $22.51 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Fiserv (FI) PT Raised to $186 at Baird
- Visa (V) PT Raised to $315 at RBC Capital
- Fiserv (FI) PT Raised to $180 at RBC Capital
Create E-mail Alert Related Categories
Analyst CommentsRelated Entities
BarclaysSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!